SUMMIT SECURITIES GROUP LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUMMIT SECURITIES GROUP LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$0
-100.0%
5
-99.4%
0.00%
-100.0%
Q2 2023$14
-6.7%
9000.0%0.00%
+100.0%
Q1 2023$15
-77.3%
900
-78.7%
0.00%
-50.0%
Q4 2022$66
-99.8%
4,225
+62.5%
0.00%
-33.3%
Q3 2022$34,000
-10.5%
2,600
-3.7%
0.00%
-40.0%
Q2 2022$38,000
-36.7%
2,700
-35.7%
0.01%
-28.6%
Q1 2022$60,000
-78.7%
4,200
-79.7%
0.01%
-46.2%
Q4 2021$282,000
-28.6%
20,700
-14.1%
0.01%
-58.1%
Q3 2021$395,000
-81.9%
24,100
-56.5%
0.03%
-82.9%
Q2 2021$2,181,000
-31.4%
55,350
-26.3%
0.18%
-48.0%
Q1 2021$3,179,000
-74.1%
75,077
+1013.9%
0.35%
-66.3%
Q4 2020$12,267,000
-31.1%
6,740
-72.9%
1.03%
-44.6%
Q3 2020$17,797,000
+0.6%
24,911
+152.5%
1.86%
-15.2%
Q2 2020$17,688,000
-10.8%
9,865
-96.3%
2.20%
-36.9%
Q1 2020$19,833,000
-4.4%
265,169
+2422.5%
3.49%
+122.4%
Q4 2019$20,740,000
+14.7%
10,5120.0%1.57%
-2.1%
Q3 2019$18,080,000
-17.1%
10,512
-69.9%
1.60%
-36.7%
Q2 2019$21,822,00034,9022.53%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders